SUSAN LINT-PIRTLE: Open Payments
NPI 1073679486 · WATERFORD, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,319 in 132 payments from 14 companies in 2025. Trend: 2023 $224 · 2024 $799 · 2025 $2,319
Food & beverage: $2,208Education: $111
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 20 | $495 |
| E.R. Squibb & Sons, L.L.C. | 29 | $495 |
| Indivior Inc. | 12 | $274 |
| Teva Pharmaceuticals USA, Inc. | 17 | $266 |
| Otsuka America Pharmaceutical, Inc. | 22 | $243 |
| Vanda Pharmaceuticals Inc. | 10 | $172 |
| Neurocrine BioSciences, Inc. | 10 | $171 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $46 |
| Braeburn Inc. | 2 | $46 |
| Janssen Pharmaceuticals, Inc | 2 | $30 |
Products named: COBENFY, SUBLOCADE, ARISTADA, FANAPT, INGREZZA, REXULTI, LYBALVI, VIVITROL.
Industry payments across MI — which companies pay providers there.
